Associate Professor, Surgery, Perelman School of Medicine
General Surgery
Dr. Peter L. Abt, MD
|
|
Give Review
Peter practices General Surgery. He graduated from Geisel School of Medicine at Dartmouth. Geisel School of Medicine at Dartmouth has a rank of 37 in research and a 29 in primary care He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Peter is a published doctor. He published 96 publications, including: 'Reply to "Increasing the Number of Organs Available to Transplant Is Separate From Ensuring Equitable Distribution of Available Organs: Both Are Important Goals".' Peter L. Abt, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Reply to "Increasing the Number of Organs Available to Transplant Is Separate From Ensuring Equitable Distribution of Available Organs: Both Are Important Goals".
- Functional Status, Time to Transplantation, and Survival Benefit of Kidney Transplantation Among Wait-Listed Candidates.
- Deceased Donor Intervention Research: A Survey of Transplant Surgeons, Organ Procurement Professionals, and Institutional Review Board Members.
- Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV/HCV-coinfected recipients.
- Repeat Kidney Transplantation After Failed First Transplant in Childhood: Past Performance Informs Future Performance.
- Graft and patient survival outcomes of a third kidney transplant.
- Use of MELD Exceptions for donation after cardiac death graft recipients relisted for Liver transplantation.
- Donation after cardiac death liver transplantation is associated with increased risk of end-stage renal Disease.
- Combined heart-Liver transplantation; implications for Liver-alone wait list mortality.
- Waiting time and explant pathology in transplant recipients with hepatocellular carcinoma: a novel study using national data.
- Superior survival using living donors and donor-recipient matching using a novel living donor risk index.
- Reframing the impact of combined heart-Liver allocation on Liver transplant waitlist candidates.
- Improving Outcomes in DCDD Liver Transplantation: There Can Only Be Strength in Numbers.
- Liver Transplantation and cirrhotomimetic hepatocellular carcinoma: Classification and outcomes.
- Revisiting multi-organ transplantation in the setting of scarcity.
- End-stage renal Disease after liver transplantation in patients with pre-transplant chronic kidney Disease.
- A Case for APRIL/BLyS Directed Therapy Not Eosinophil Directed Therapy for Alloantibody Elimination.
- Early rehospitalization after kidney transplantation: assessing preventability and prognosis.
- Sustained reduction of alloantibody secreting plasma cells and donor specific antibody with proteasome inhibition in mice.
- Functional Status and Survival After Kidney Transplantation.
- End-Stage Kidney Disease After Pediatric Nonrenal Solid Organ Transplantation.
- The donor hemodynamic profile presages graft survival in donation after cardiac death Liver transplantation.
- Interleukin 5 immunotherapy depletes alloreactive plasma cells.
- Simultaneous thoracic and Abdominal transplantation: can we justify two organs for one recipient?
- Biliary complications adversely affect patient and graft survival after liver retransplantation.
- Roux-en-Y gastric bypass compared with aggressive diet and exercise therapy for morbidly obese patients awaiting renal transplant: a decision Analysis.
- Challenges to Research and Innovation to Optimize Deceased Donor Organ Quality and Quantity.
- Risk Factors for End-Stage Kidney Disease After Pediatric Liver Transplantation.
- Cardiac arrest associated with reperfusion of the Liver during transplantation: incidence and proposal for a management algorithm.
- Elevated serum creatinine in a kidney transplant recipient: unusual suspect.
- Efficacy and Safety of Extended-Duration Inpatient-to-Outpatient Rabbit Antithymocyte Globulin Induction in De Novo Kidney Transplant Recipients: 6-Month Outcomes.
- Risk of End-Stage Renal Disease Among Liver Transplant Recipients With Pretransplant Renal Dysfunction.
- The Influence of Induction Therapy for Kidney Transplantation after a Non-Renal Transplant.
- Underutilization of A2 ABO incompatible kidney transplantation.
- Donation after cardiac death in pediatric organ transplantation.
- Treatment options and strategies for antibody mediated rejection after renal transplantation.
- The right organ for the right recipient: the Ninth Annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium.
- Assessment of variation in live donor kidney transplantation across transplant centers in the United States.
- Donor-derived Strongyloides stercoralis infections in renal transplant recipients.
- Liver transplantation in patients with cystic fibrosis: Analysis of United Network for Organ Sharing data.
- Increased early graft failure in right-sided living donor nephrectomy.
- Estimated supply of organ donors after circulatory determination of death: a population-based cohort study.
- Comparative Analysis of Outcome in Patients With Hepatocellular Carcinoma Exceeding the Milan Criteria Treated With Liver Transplantation Versus Partial Hepatectomy.
- How should we use age to ration health care? Lessons from the case of kidney transplantation.
- Kidney transplantation in patients with a prior heart transplant.
- Therapy of renal artery Aneurysms in New York State: outcomes of patients undergoing open and endovascular repair.
- The cumulative effects of cold ischemic time and older donor age on Liver graft survival.
- Donation after cardiac death in the US: history and use.
- Elective transjugular intrahepatic portosystemic shunt creation for portal decompression in the immediate pretransplantation period in adult living related Liver trans...
- Appendicitis among Liver transplant recipients.
- Survival among pediatric Liver transplant recipients: impact of segmental grafts.
- Early kidney dysfunction post liver transplantation predicts late chronic kidney Disease.
- Predicting outcome after liver transplantation: utility of the model for end-stage liver Disease and a newly derived discrimination function.
- Survival following Liver transplantation from non-heart-beating donors.
- Intrahepatic gas.
- ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation.
- Successful Liver, kidney, and pancreas transplantation from a donor with cerebral emboli from a left atrial myxoma.
- Predictors of late kidney dysfunction post-Liver transplantation.
- Allograft survival following adult-to-adult living donor Liver transplantation.
- Anti-interferon antibody inhibits natural killer cell activity in HSV-2 genital infection in C57BL/6J mice.
- Human herpesvirus 6 in monocytes of transplant patients.
- Analysis of thymectomy for myasthenia gravis in older patients: a 20-year single institution experience.
- Dynamic retention: a technique for closure of the complex abdomen in critically ill patients.
- Factors differentially correlated with the outcome of Liver transplantation in hcv+ and HCV- recipients.
- Tree stand falls: a persistent cause of sports injury.
- Liver transplantation from controlled non-heart-beating donors: an increased incidence of Biliary complications.
- Home glucometer monitoring markedly improves diagnosis of post renal transplant diabetes mellitus in renal transplant recipients.
- Survival outcome after hepatic retransplantation for hepatitis C virus-positive and -negative recipients.
- Transplantation of Liver grafts from older donors: impact on recipients with hepatitis C virus infection.
- Change in oral absorption of tacrolimus in a Liver transplant recipient after reversal of jejunoileal bypass: case report.
- Use of hepatitis B core antibody-positive Liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin...
- Intravenous mycophenolate mofetil with low-dose oral tacrolimus and steroid induction for live donor Liver transplantation.
- Question of using valganciclovir for cytomegalovirus (CMV) infection prophylaxis in post-Liver transplant recipients.
- Transplantation for type I diabetes: comparison of Vascularized whole-organ pancreas with isolated pancreatic islets.
- Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list.
- Nephrogenic systemic fibrosis among Liver transplant recipients: a single institution experience and topic update.
- University of Wisconsin versus histidine-tryptophan-ketoglutarate for tissue preservation in live-donor Liver transplantation.
- HCV antibody quantitative levels in Liver transplant patients: do they have any relevance in clinical practice?
- Modification of a biventricular assist device to facilitate preservative infusion and organ recovery in a nonheart-beating donor.
- Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-Liver transplant bi...
- Pediatric Liver and kidney transplantation with allografts from DCD donors: A review of UNOS data.
- Postoperative impact of intraoperative biochemical changes at the completion of parenchymal division in living-donor Liver transplantation.
- Pharmacokinetics of mycophenolic acid in Liver transplant patients after intravenous and oral administration of mycophenolate mofetil.
- Survival outcomes in Liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
- Living-donor Liver transplantation in the United States: identifying donors at risk for perioperative complications.
- Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma.
- Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor Liver transplantation and live donor live...
- Pharmacokinetics of tacrolimus in living donor Liver transplant and deceased donor Liver transplant recipients.
- Minimizing morbidity of organ donation: Analysis of factors for perioperative complications after living-donor nephrectomy in the United States.
- Pharmacokinetics of mycophenolic acid in live donor Liver transplant patients vs deceased donor Liver transplant patients.
- Stratifying risk of Biliary complications in adult living donor liver transplantation by magnetic resonance cholangiography.
- High mortality in orthotopic Liver transplant recipients who require hemodialysis.
- Kidney transplantation at the University of Pennsylvania: 1998-2008.
- Wait list death and survival benefit of kidney transplantation among nonrenal transplant recipients.
- Transplant nephrectomy: histologic findings - a single center study.
Schools
Dartmouth College
Procedures Preformed
- Adrenalectomy
- Arteriovenous Shunt Creation
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Embolectomy, Thrombectomy, or Vessel Exploration
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anorectal Abscess
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
University of Rochester -
Geisel School of Medicine at Dartmouth
Hospital
-
Hospital of the University of Pennsylvania -
Penn Presbyterian Medical Center
Drug Facts
| NPI NUMBER | 1649206590 | |
| NPPES Provider LastName | ABT | |
| NPPES Provider FirstName | PETER | |
| NPPES Provider ZIPCode | 191044206 | |
| NPPES Provider State | PA | |
| Specialty Description | General Surgery | |
| Total Claim Count | 117.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1649206590 |
| Last Name Of The Provider | ABT |
| First Name Of The Provider | PETER |
| View All |
Similar Doctors
|
|
Dr. Sarosh N. Zafar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Austin D. Williams, MD |
|
|
Dr. Jonas A. Nelson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew H. Levine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kofi O. Atiemo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremiah G. Allen, MD |
|
|
Dr. Mihir M. Shah, MD |
|
Dr. Jeffrey M. Farma, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jan A. Olenginski, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Allen H. Bar, MD
This Doctor is OpenDoctor Recommended.
|